AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glymeko M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Athiko Life Sciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glymeko M 2mg/500mg Tablet

Diabexe Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as advised by your doctor. Lifestyle choices are integral to diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals should consult their physician before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glymeko M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glymeko M 2mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Glymeko M 2mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with food.

Common Side effects of Glymeko M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glymeko M 2mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glymeko M 2mg/500mg tablets should be administered with a meal.

How Glymeko M 2mg/500mg Tablet works:

Glymeko M 2mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glymeko M 2mg/500mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glymeko M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Glymeko M 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose levels are abnormally low or elevated. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glymeko M 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is necessary. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glymeko M 2mg/500mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; Glymeko M 2mg/500mg tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glymeko M 2mg/500mg Tablet :

Should you forget a Glymeko M 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glymeko M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glymeko M 2mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medicine. Prevent access by children, pets, and other individuals.
Glymeko M 2mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially dangerous side effect is more likely in individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Glymeko M 2mg/500mg Tablets and prompt medical attention.
Glymeko M 2mg/500mg tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glymeko M 2mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse events such as lactic acidosis have also been reported. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glymeko M 2mg/500mg Tablet consumption can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, according to some studies, include annual supplemental Vitamin B12 intake.
Indeed, Glymeko M 2mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glymeko M 2mg/500mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glymeko M 2mg/500mg Table...
65
MRP 79
17% off